We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
QIAGEN N.V. today announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V., to develop innovative bioinformatics and assay solutions to ....
Qiagen is launching three next-generation sequencing workflows for cancer research, expanding the clinical oncology footprint of the German company’s GeneReader platform.